Quality key factors
Factor
Value
Sales Growth (5y)
-1.70%
EBIT Growth (5y)
-6.10%
EBIT to Interest (avg)
0.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.10
Tax Ratio
18.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-3.56%
ROE (avg)
3.58%
Valuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
33
Price to Book Value
66.50
EV to EBIT
33.49
EV to EBITDA
33.00
EV to Capital Employed
67.49
EV to Sales
2.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-17.42%
ROE (Latest)
164.18%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Movement
8What is working for the Company
PAT(9M)
Higher at Rs 2.23 Cr
EPS(Q)
Highest at Rs 0.31
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Welcure Drugs
Profit After Tax (PAT) - Half Yearly
At Rs 2.25 cr has Grown at 1,830.77%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Half Yearly
Higher at Rs 2.25 cr
than preceding 12 month period ended Dec 2024 of Rs -0.18 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.31
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)